Loading page...

Back
PAR-25-442 Open
Send to:
National Institutes of Health United States

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Open

Overview

Funding agency
National Institutes of Health HHS-NIH11
Reference
PAR-25-442
Region
United States
Source
Grants.gov (US Federal)

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method or agent that is selective for one or more targets within that target class. This NOFO is intended to…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Related grants

Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) National Institutes of Health Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) National Institutes of Health Research Grants in Clinical Informatics (R01 Clinical Trial Optional) National Institutes of Health

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top